These criteria ensured that only highly significant pathways were considered, supporting the therapeutic implications of GSK-3β inhibition.
← all excerpts
Computational identification of phytochemicals as glycogen synthase kinase 3 beta (GSK3β) inhibitors for therapeutic applications in chronic diseases.
1
—
—